Allergy Therapeutics Plc has been mentioned in a Form 8.5 (EPT/RI) disclosure by Panmure Gordon (UK) Limited. The disclosure states that Panmure Gordon (UK) Limited, as an exempt principal trader, has made purchases of 400,000 securities of Allergy Therapeutics Plc at a price of 0.0141 per unit. There were no sales of securities by Panmure Gordon (UK) Limited. The disclosure does not mention any cash-settled derivative transactions or stock-settled derivative transactions. There are no indemnity or option arrangements, agreements, or understandings related to relevant securities mentioned in the disclosure. The contact person for the disclosure is Freddie Wooding, and the date of disclosure is 10/11/2023.